Pathstone Holdings
HOLX

Pathstone Holdings’s Hologic HOLX Stock Holding History

Pathstone Holdings’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-37,164
Closed -$2.81M – 2377
2026
Q1 		$2.81M Buy
37,164
+27
+0.1% +$2.03K 0.01% 854
2025
Q4 		$2.77M Sell
37,137
-16,672
-31% -$1.22M 0.01% 860
2025
Q3 		$3.63M Buy
53,809
+207
+0.4% +$13.7K 0.01% 694
2025
Q2 		$3.49M Buy
53,602
+22,902
+75% +$1.37M 0.01% 695
2025
Q1 		$1.9M Buy
30,700
+184
+0.6% +$12.2K 0.01% 1019
2024
Q4 		$2.2M Buy
30,516
+785
+3% +$61.3K 0.01% 918
2024
Q3 		$2.42M Buy
29,731
+2,121
+8% +$170K 0.01% 869
2024
Q2 		$2.05M Buy
27,610
+1,319
+5% +$98.9K 0.01% 910
2024
Q1 		$2.05M Sell
26,291
-1,214
-4% -$90.3K 0.01% 884
2023
Q4 		$1.97M Buy
+27,505
New +$1.92M 0.01% 749

Other funds holding HOLX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Pathstone Holdings's HOLX Position: Q2 2026 in Review

Pathstone Holdings sold out of Hologic (HOLX) in Q2 2026, closing a stake of 37,164 shares — an estimated $2.81M sold.

Pathstone Holdings first reported a position in HOLX in Q4 2023 and held it in 10 quarters. The position peaked at $3.63M in Q3 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Pathstone Holdings reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Pathstone Holdings sold 37,164 Hologic shares in Q2 2026, an estimated $2.81M.
  • Pathstone Holdings first reported a position in Hologic in Q4 2023 and held it in 10 quarters.
  • Pathstone Holdings's Hologic position peaked at $3.63M in Q3 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.